Lakefront Biotherapeutics (LKFT) Change in Accured Expenses (2018 - 2026)
Lakefront Biotherapeutics (LKFT) reported Change in Accured Expenses of -$50.8 million for Q1 2026, down 31043.13% year-over-year from N/an in Q1 2025, and down 31043.13% quarter-over-quarter from -$163042.1 in Q1 2025.
Lakefront Biotherapeutics (LKFT) Change in Accured Expenses (2018 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has 5 years of Change in Accured Expenses data on file, last reported at -$50.8 million in Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at -$50.8 million, down 31043.13% year-over-year; the trailing twelve-month figure through Mar 2026 was -$50.9 million (down 915.85% YoY), and the FY2015 annual result was -$137014.7, down 506.02% from the prior year.
- Change in Accured Expenses fell to -$50.8 million in Q1 2026 per LKFT's latest filing, from -$163042.1 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at -$81268.2 in Q3 2024 and troughed at -$50.8 million in Q1 2026.
- A 3-year average of -$17.0 million and a median of -$163042.1 in 2025 frame the typical range for Change in Accured Expenses.
- On a YoY basis, Change in Accured Expenses climbed as much as 31043.13% in 2026 and fell as far as 31043.13% in 2026.
- A 3-year view of Change in Accured Expenses shows it stood at -$81268.2 in 2024, then plunged by 100.62% to -$163042.1 in 2025, then slumped by 31043.13% to -$50.8 million in 2026.
- Business Quant data shows LKFT's Change in Accured Expenses at -$50.8 million in Q1 2026, -$163042.1 in Q1 2025, and -$81268.2 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 931,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Lakefront Biotherapeutics | 9.64 Bn | 9.64 Bn | 1.97 Mn | -50.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.78 Mn |
| Mar 31, 2026 | -50.78 Mn |
| Mar 31, 2025 | -163,042.09 |
| Mar 31, 2025 | -163,042.09 |
| Sep 30, 2024 | -81,268.24 |
| Sep 30, 2024 | -81,268.24 |
| Sep 30, 2019 | -2.15 Mn |
| Sep 30, 2019 | -2.15 Mn |
| Jun 30, 2019 | -2.62 Mn |
| Jun 30, 2019 | -2.62 Mn |
| Mar 31, 2019 | -1.37 Mn |
| Mar 31, 2019 | -1.37 Mn |
| Sep 30, 2018 | -943,297.76 |
| Sep 30, 2018 | -943,297.76 |
| Jun 30, 2018 | -455,895.77 |
| Jun 30, 2018 | -455,895.77 |
| Mar 31, 2018 | -417,701.15 |
| Mar 31, 2018 | -417,701.15 |